z-logo
open-access-imgOpen Access
Manufacturing Process of SER-109, a Purified Investigational Microbiome Therapeutic, Reduces Risk of Coronavirus Transmission From Donor Stool
Author(s) -
Christopher McChalicher,
Ahmad A. Abdul-Aziz,
S Steve Zhou,
Mary-Jane Lombardo,
Brooke Hasson,
John Auniņš,
Barbara McGovern,
David S. Ege
Publication year - 2022
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofac448
Subject(s) - medicine , covid-19 , transmission (telecommunications) , microbiome , coronavirus , manufacturing process , virology , microbiology and biotechnology , bioinformatics , biology , infectious disease (medical specialty) , electrical engineering , engineering , materials science , composite material , disease , outbreak

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom